Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 4, 2013, Pages 334-341

  Otten, Amber M ^a   Maas, Angela Hem ^b   Ottervanger, Jan Paul ^a   Kloosterman, Anita ^a   Van ’t Hof, Arnoud Wj ^a   Dambrink, Jan Henk E ^a   Gosselink, At Marcel ^a   Hoorntje, Jan C A ^a   Suryapranata, Harry ^a,b   de Boer, Menko Jan ^b  

^a ISALA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute coronary syndrome; age; gender; STEMI; women

Indexed keywords

ACUTE CORONARY SYNDROME; AGE; GENDER; STEMI; WOMEN;

AGE FACTORS; AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MORBIDITY; MYOCARDIAL INFARCTION; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84906914785     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612475270     Document Type: Article

References (46)

1. Vakili BA, Kaplan RC and Brown DL. Sex-based differences in early mortality of patients undergoing primary angioplasty for first myocardial infarction. Circulation 2001; 104: 3034–3038.
2. Peterson ED, Lansky AJ, Kramer J, et al.; National Cardiovascular Network Clinical Investigators. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 2001; 88: 359–364.
3. Duvernoy CS, Smith DE, Manohar P, et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. Am Heart J 2010; 159: 677–683.
4. Singh M, Rihal CS, Gersh BJ, et al. Mortality between men and women after percutaneous coronary interventions: 25-year, single-center experience. J Am Coll Cardiol 2008; 51: 2313–2320.
5. Akhter N, Milford-Beland S, Roe MT, et al. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 2009; 157: 141–148.
6. Radovanovic D, Erne P, Urban P, et al.; AMIS Plus Investigators. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20290 patients from the AMIS plus registry. Heart 2007; 93: 1369–1375.
7. Diercks DB, Owen KP, Kontos MC, et al. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network−Get with the Guidelines (NCDR ACTION Registry−GWTG). Am Heart J 2010; 160: 80–87.
8. Kaul P, Armstrong PW, Sookram S, et al. Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction. Am Heart J 2011; 161: 91–97.
9. Cheng CI, Yeh KH, Chang HW, et al. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 2004; 126: 47–53.
10. Benamer H, Tafflet M, Bataille S, et al. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI registry. EuroIntervention 2011; 6: 1029–1031.
11. Milcent C, Dormont B, Durand-Zaleski I, et al. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction. Microsimulation analysis of the 1999 nationwide French hospitals database. Circulation 2007; 115: 833–839.
12. Jneid H, Fonarow GC, Cannon CP, et al.; Get With the Guidelines Steering Committee and Investigators. Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008; 118: 2803–2810.
13. Alexander KP, Chen AY, Newby LK, et al.; CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Investigators. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors. Results from the CRUSADE initiative. Circulation 2006; 114: 1380–1387.
14. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999; 341: 226–232.
15. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after acute myocardial infarction. N Engl J Med 1999; 341:217–225.
16. Berger JS and Brown DL. Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol 2006; 98: 1140–1143.
17. Berger JS, Elliott L, Gallup D, et al. Sex differences in mortality after acute coronary syndromes. JAMA 2009; 302: 874–882.
18. Lawesson SS, Stenestrand U, Lagerqvist B, et al. Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction. Heart 2010; 96: 453–459.
19. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82: 269–272.
20. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354–1363.
21. Frink RJ. Gender gap, inflammation and acute coronary disease: are women resistant to atheroma growth? Observations at autopsy. J Invasive Cardiol 2009; 21: 270–277.
22. Shaw L J, Bugiardini R and Bairey Merz C N.Women and ischemic heart disease. J Am Coll Cardiol 2009; 54: 1561–1575.
23. Champney KP, Frederick PD, Bueno H, et al.; NRMI Investigators. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart 2009; 95: 895–899.
24. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings: TIMI Study Group. N Engl J Med 1985; 312: 932–936.
25. Van't Hof AWJ, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998; 97: 2302–2306.
26. De Boer MJ, Suryapranata H, Hoorntje JCA, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994; 90: 753–761.
27. Schoenfeld D. Residuals for the proportional hazards regression model. Biometrika 1982; 69: 239–241.
28. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 1988; 16: 1141–1154.
29. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 1988; 16: 1141–1154.
30. Bairey Merz C N.The Yentl syndrome is alive and well. Eur Heart J 2011; 32: 1313–1315.
31. Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043–1047.
32. Grundtvig M, Hagen TP, German M, et al. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil 2009; 16: 174–179.
33. Barbieri SS, Zacchi E, Amadio P, et al. Cytokines present in smokers'serum interact with smoke components to enhance endothelial dysfunction. Cardiovascular Research 2011; 90: 475–483.
34. Mendelsohn ME and Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801–1811.
35. Tanis BC, van den Bosch MAAJ, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001; 345: 1787–1793.
36. Lidegaard Ø, Løkkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366: 2257–2266.
37. Bairey MCN, Johnson BD, Sharaf BL, et al.; WISE Study Group. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41: 413–419.
38. Ingelsson E, Lundholm C, Johansson ALV, et al. Hysterectomy and the risk of cardiovascular disease: a population based cohort study. Eur Heart J 2011; 32: 745–750.
39. Kramer MCA, Rittersma SZH de Winter RJ, et al. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol 2010; 55: 122–132.
40. Kruk M, Pregowski J, Mintz GS, et al. Intravascular ultrasonic study of gender differences in ruptured coronary plaque morphology and its associated clinical presentation. Am J Cardiol 2007; 100: 185–189.
41. Bugiardini R and Bairey Merz C N.Angina with ‘normal’ coronary arteries: a changing philosophy. JAMA 2005; 293: 477–484.
42. Smilowitz NR, Sampson BA, Abtrecht CR, et al. Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study. Am Heart J 2011; 161: 681–688.
43. Ong P, Athanasiadis A, Hill S, et al. Coronary artery spasm as a frequent cause of acute coronary syndrome. J Am Coll Cardiol 2008; 52: 523–527.
44. Ndrepepa G, Tiroch K, Keta D, et al. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Interv 2010; 3: 27–33.
45. McFadden P, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519–1921.
46. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126–2130.